胃癌腹膜转移的空间分辨微环境与肿瘤微环境改变
本研究对326例患者的548份样本进行多组学分析,涵盖原发灶、癌旁正常组织、腹膜转移灶及邻近正常腹膜,结合全外显子测序、全转录组测序与数字空间谱分析。结果显示,原发灶中ELF3、CDH1、PIGR突变及基质浸润、M2巨噬细胞富集等微环境特征与腹膜转移风险增加相关,腹膜转移灶中CLDN18.2与FGFR2b表达低于原发灶。
要点
- 原发灶ELF3、CDH1、PIGR突变及基质浸润、M2巨噬细胞富集与腹膜转移风险增加相关。
- 胃癌腹膜转移与肝转移相比具有不同的转录程序和免疫组成。
- 腹膜转移灶中CLDN18.2与FGFR2b表达低于原发灶。
核心结论
- 本研究全面刻画了胃癌腹膜转移的分子特征,揭示了经腹腔播散转移的关键生物学原则。
- 所识别的预测标志物、治疗靶点及肿瘤微环境改变可能为靶向干预和改善患者结局提供潜在途径。
研究设计与样本
- 对326例患者的548份样本进行多组学分析,样本包括原发肿瘤、配对的正常组织、腹膜转移灶及邻近正常腹膜组织。
- 采用全外显子测序、全转录组测序和数字空间谱分析,研究腹膜转移相关的分子改变、基因表达模式和肿瘤微环境特征。
主要发现
- 原发肿瘤中ELF3、CDH1和PIGR突变以及基质浸润、M2巨噬细胞富集等肿瘤微环境特征与腹膜转移风险增加相关。
- 胃癌腹膜转移与肝转移相比,具有不同的转录程序和免疫组成。
- 腹膜转移灶与原发肿瘤之间治疗靶点表达存在差异,腹膜转移灶中CLDN18.2和FGFR2b表达较低。
- 研究揭示了肿瘤微环境在腹膜微环境重编程中的作用,并发现即使无临床腹膜转移的早期胃癌也存在转移前微环境形成的证据。
- 人源化小鼠模型验证了经腹腔播散转移过程中腹膜微环境重塑。
关键数值与推荐
- 原发肿瘤中ELF3、CDH1、PIGR突变及基质浸润、M2巨噬细胞富集等特征与腹膜转移风险增加相关。
- 腹膜转移灶中CLDN18.2和FGFR2b表达低于原发肿瘤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Peritoneal metastasis (PM) in gastric cancer (GC) is associated with poor prognosis and significant morbidity. We sought to understand the genomic, transcriptomic, and tumor microenvironment (TME) features that contribute to peritoneal organotropism in GC. METHODS: We conducted a comprehensive multi-omic analysis of 548 samples from 326 patients, including primary tumors, matched normal tissues; peritoneal metastases, and adjacent-normal peritoneal tissues. We used whole exome sequencing, whole transcriptome sequencing, and digital spatial profiling to investigate molecular alterations, gene expression patterns, and TME characteristics associated with PM. RESULTS: Our analysis identified specific genomic alterations in primary tumors, including mutations in ELF3, CDH1, and PIGR, and TME signatures, such as stromal infiltration and M2 macrophage enrichment, associated with increased risk of PM. We observed distinct transcriptional programs and immune compositions in GCPM compared with liver metastases, highlighting the importance of the TME in transcoelomic metastasis. We found differential expression of therapeutic targets between primary tumors and PM, with lower CLDN18.2 and FGFR2b expression in PM. We unravel the roles of the TME in niche reprogramming within the peritoneum, and provide evidence of pre-metastatic niche conditioning even in early GC without clinical PM. These findings were further validated using a humanized mouse model, which demonstrated niche remodeling in the peritoneum during transcoelomic metastasis. CONCLUSION: Our study provides a comprehensive molecular characterization of GCPM and unveils key biological principles underlying transcoelomic metastasis. The identified predictive markers, therapeutic targets, and TME alterations offer potential avenues for targeted interventions and improved patient outcomes.
引用
- Zhao JJ, Ong CJ, Srivastava S, et al. Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases. Gastroenterology. 2024. PMID: 39147169. doi:10.1053/j.gastro.2024.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。